vs

Side-by-side financial comparison of Neuronetics, Inc. (STIM) and Exzeo Group, Inc. (XZO). Click either name above to swap in a different company.

Exzeo Group, Inc. is the larger business by last-quarter revenue ($55.5M vs $41.8M, roughly 1.3× Neuronetics, Inc.). Exzeo Group, Inc. runs the higher net margin — 36.7% vs -17.2%, a 54.0% gap on every dollar of revenue. On growth, Neuronetics, Inc. posted the faster year-over-year revenue change (85.7% vs 6.0%). Exzeo Group, Inc. produced more free cash flow last quarter ($25.1M vs $692.0K).

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. 

Exzeo Group, Inc. is a global technology firm specializing in cloud-native SaaS solutions for the insurance industry. Its core product portfolio includes claims processing platforms, policy administration tools, and underwriting automation systems, serving insurance carriers, third-party administrators, and independent adjusters across North America and European markets.

STIM vs XZO — Head-to-Head

Bigger by revenue
XZO
XZO
1.3× larger
XZO
$55.5M
$41.8M
STIM
Growing faster (revenue YoY)
STIM
STIM
+79.8% gap
STIM
85.7%
6.0%
XZO
Higher net margin
XZO
XZO
54.0% more per $
XZO
36.7%
-17.2%
STIM
More free cash flow
XZO
XZO
$24.5M more FCF
XZO
$25.1M
$692.0K
STIM

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
STIM
STIM
XZO
XZO
Revenue
$41.8M
$55.5M
Net Profit
$-7.2M
$20.4M
Gross Margin
52.0%
59.0%
Operating Margin
-12.1%
45.2%
Net Margin
-17.2%
36.7%
Revenue YoY
85.7%
6.0%
Net Profit YoY
43.2%
13.7%
EPS (diluted)
$-0.10
$0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
STIM
STIM
XZO
XZO
Q1 26
$55.5M
Q4 25
$41.8M
$53.3M
Q3 25
$37.3M
$55.2M
Q2 25
$38.1M
Q1 25
$32.0M
Q4 24
$22.5M
Q3 24
$18.5M
Q2 24
$16.4M
Net Profit
STIM
STIM
XZO
XZO
Q1 26
$20.4M
Q4 25
$-7.2M
$22.0M
Q3 25
$-9.0M
$21.2M
Q2 25
$-10.1M
Q1 25
$-12.7M
Q4 24
$-12.7M
Q3 24
$-13.3M
Q2 24
$-9.8M
Gross Margin
STIM
STIM
XZO
XZO
Q1 26
59.0%
Q4 25
52.0%
65.4%
Q3 25
45.9%
61.2%
Q2 25
46.6%
Q1 25
49.2%
Q4 24
66.2%
Q3 24
75.6%
Q2 24
74.0%
Operating Margin
STIM
STIM
XZO
XZO
Q1 26
45.2%
Q4 25
-12.1%
50.3%
Q3 25
-19.6%
49.4%
Q2 25
-21.1%
Q1 25
-34.4%
Q4 24
-51.0%
Q3 24
-41.7%
Q2 24
-51.7%
Net Margin
STIM
STIM
XZO
XZO
Q1 26
36.7%
Q4 25
-17.2%
41.2%
Q3 25
-24.3%
38.3%
Q2 25
-26.6%
Q1 25
-39.6%
Q4 24
-56.4%
Q3 24
-72.0%
Q2 24
-59.8%
EPS (diluted)
STIM
STIM
XZO
XZO
Q1 26
$0.22
Q4 25
$-0.10
$0.25
Q3 25
$-0.13
$0.25
Q2 25
$-0.15
Q1 25
$-0.21
Q4 24
$-0.34
Q3 24
$-0.44
Q2 24
$-0.33

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
STIM
STIM
XZO
XZO
Cash + ST InvestmentsLiquidity on hand
$28.1M
$231.4M
Total DebtLower is stronger
$65.8M
Stockholders' EquityBook value
$22.4M
$274.9M
Total Assets
$141.6M
$379.8M
Debt / EquityLower = less leverage
2.94×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
STIM
STIM
XZO
XZO
Q1 26
$231.4M
Q4 25
$28.1M
$305.4M
Q3 25
$28.0M
$140.9M
Q2 25
$11.0M
Q1 25
$20.2M
Q4 24
$18.5M
Q3 24
$20.9M
Q2 24
$42.6M
Total Debt
STIM
STIM
XZO
XZO
Q1 26
Q4 25
$65.8M
Q3 25
$65.7M
Q2 25
$55.5M
Q1 25
$55.3M
Q4 24
$55.2M
Q3 24
$46.0M
Q2 24
$59.8M
Stockholders' Equity
STIM
STIM
XZO
XZO
Q1 26
$274.9M
Q4 25
$22.4M
$254.2M
Q3 25
$27.4M
$78.4M
Q2 25
$27.1M
Q1 25
$35.5M
Q4 24
$27.7M
Q3 24
$9.4M
Q2 24
$19.4M
Total Assets
STIM
STIM
XZO
XZO
Q1 26
$379.8M
Q4 25
$141.6M
$347.7M
Q3 25
$145.5M
$182.3M
Q2 25
$134.7M
Q1 25
$142.0M
Q4 24
$140.9M
Q3 24
Q2 24
$96.8M
Debt / Equity
STIM
STIM
XZO
XZO
Q1 26
Q4 25
2.94×
Q3 25
2.40×
Q2 25
2.05×
Q1 25
1.56×
Q4 24
1.99×
Q3 24
4.90×
Q2 24
3.08×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
STIM
STIM
XZO
XZO
Operating Cash FlowLast quarter
$908.0K
Free Cash FlowOCF − Capex
$692.0K
$25.1M
FCF MarginFCF / Revenue
1.7%
45.3%
Capex IntensityCapex / Revenue
0.5%
0.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-21.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
STIM
STIM
XZO
XZO
Q1 26
Q4 25
$908.0K
Q3 25
$-785.0K
$89.0M
Q2 25
$-3.5M
Q1 25
$-17.0M
Q4 24
$-8.6M
Q3 24
$-5.4M
Q2 24
$-5.0M
Free Cash Flow
STIM
STIM
XZO
XZO
Q1 26
$25.1M
Q4 25
$692.0K
$97.5M
Q3 25
$-899.0K
$86.6M
Q2 25
$-3.8M
Q1 25
$-17.2M
Q4 24
$-8.7M
Q3 24
$-5.8M
Q2 24
$-5.6M
FCF Margin
STIM
STIM
XZO
XZO
Q1 26
45.3%
Q4 25
1.7%
182.8%
Q3 25
-2.4%
156.9%
Q2 25
-9.9%
Q1 25
-53.8%
Q4 24
-38.6%
Q3 24
-31.3%
Q2 24
-34.0%
Capex Intensity
STIM
STIM
XZO
XZO
Q1 26
0.6%
Q4 25
0.5%
5.3%
Q3 25
0.3%
4.4%
Q2 25
0.7%
Q1 25
0.7%
Q4 24
0.4%
Q3 24
2.1%
Q2 24
3.7%
Cash Conversion
STIM
STIM
XZO
XZO
Q1 26
Q4 25
Q3 25
4.21×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons